- About this Journal
- Abstracting and Indexing
- Aims and Scope
- Annual Issues
- Article Processing Charges
- Articles in Press
- Author Guidelines
- Bibliographic Information
- Citations to this Journal
- Contact Information
- Editorial Board
- Editorial Workflow
- Free eTOC Alerts
- Publication Ethics
- Reviewers Acknowledgment
- Submit a Manuscript
- Subscription Information
- Table of Contents
Evidence-Based Complementary and Alternative Medicine
Volume 2012 (2012), Article ID 606183, 10 pages
doi:10.1155/2012/606183
Different Effects of Resveratrol on Dose-Related Doxorubicin-Induced Heart and Liver Toxicity
1Medical Biology Unit, Medical University of Lublin, 20-059 Lublin, Poland
2Human Anatomy Department, Medical University of Lublin, 20-059 Lublin, Poland
3Histology and Embryology Department, Medical University of Lublin, 20-059 Lublin, Poland
4Department of Pulmonolgy, Oncology and Alergology, Medical University of Lublin, 20-059 Lublin, Poland
5Clinical Pathomorphology Department, Medical University of Lublin, 20-059 Lublin, Poland
6Department of Toxicology, Poznan University of Medical Sciences, 60-780 Poznan, Poland
Received 18 April 2012; Revised 17 October 2012; Accepted 24 October 2012
Academic Editor: R. Govindarajan
Copyright © 2012 Jaroslaw Dudka et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
How to Cite this Article
Jaroslaw Dudka, Renata Gieroba, Agnieszka Korga, et al., “Different Effects of Resveratrol on Dose-Related Doxorubicin-Induced Heart and Liver Toxicity,” Evidence-Based Complementary and Alternative Medicine, vol. 2012, Article ID 606183, 10 pages, 2012. doi:10.1155/2012/606183